A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 7 February 2023) has been published and includes articles on: COVID-19 vaccines and medicines: updates for February 2023 Letters and medicine recalls sent to healthcare professionals in January 2023 To see the latest MHRA Drug Safety Updates in full, visit
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free). MSN/2023/023 Tier 3 – high impact Date of issue 27th February 2023 Latanoprost (Monopost®) 50microgram/ml eye drops 0.2ml unit dose (preservative free) is out of stock until 17th March
Read moreThe Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item
Read moreClass 4 Medicines Defect Information: Zestoretic 20mg/12.5mg tablets (Atnahs Pharma UK) Drug alert number: EL (23)A/05 Date issued: 27 February 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zestoretic 20mg/12.5mg Tablets, PL 43252/0035 SNOMED Code: 17403011000001101 Batch number Expiry date Pack size First distributed
Read moreFrom April 1st PSNC will be renaming to Community Pharmacy England and putting in place a new communications and engagement strategy. We want to engage better and more regularly with pharmacy owners, to hear more of your views and ideas, and to enable to you to input more directly into the organisation. As we develop
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 50mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP048 Estradot® 50mcg patches expires at 23.59pm on Friday 24 February 2023. After this date, any prescriptions for Estradot® 50mcg patches must be
Read moreCommunity pharmacy contractors are reminded that they have one week left to make their Pharmacy Quality Scheme (PQS) 2022/23 declaration through the MYS portal, as the window for claiming this payment will then close. Contractors must have evidence to demonstrate meeting the gateway criteria and the domains that they have claimed for by the end of 31st
Read moreHealth Education England is offering more independent prescribing courses from March 2023 for community pharmacists, including locums. This training enables pharmacists to support patients from diagnosis to prescribing, and to provide advice and follow-up – while also helping them to feel confident and prepared for the new challenges of their role. Courses will be available
Read moreAt the start of this month, Independent community pharmacy contractors and non-CCA Multiple contractors were asked to check relevant PSNC information, including their NHS contracts/premises and contact email addresses, as part of preparations for this year’s PSNC elections. The notice with this information came by letter and/or e-mail from Civica Election Services (formerly Electoral Reform Services),
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Dalteparin (Fragmin®) 10,000units/4mL solution for injection ampoule. MSN/2023/021 Tier 3 – high impact Date of issue 21st February 2023 Dalteparin (Fragmin®) 10,000units/4mL solution for injection ampoule is due to be out of stock from mid-February 2023 until late March 2023 whilst
Read more
